Identification of a novel de novo mutation of CREBBP in a patient with Rubinstein-Taybi syndrome by targeted next-generation sequencing: a case report

2016 ◽  
Vol 47 (1) ◽  
pp. 144-149 ◽  
Author(s):  
Kunka Kamenarova ◽  
Emil Simeonov ◽  
Reni Tzveova ◽  
Daniela Dacheva ◽  
Marin Penkov ◽  
...  
2019 ◽  
Vol 12 (1) ◽  
Author(s):  
Angélica Martínez-Hernández ◽  
Julieta Larrosa ◽  
Francisco Barajas-Olmos ◽  
Humberto García-Ortíz ◽  
Elvia C. Mendoza-Caamal ◽  
...  

2020 ◽  
pp. 1-6
Author(s):  
Selma Demir ◽  
Hakan Gürkan ◽  
Veysel Öz ◽  
Sinem Yalçıntepe ◽  
Emine İ. Atlı ◽  
...  

Wiedemann-Steiner syndrome (WDSTS) is a rare autosomal dominant disorder with a variable clinical phenotype including synophrys, hypertelorism, thick eyebrows, long eyelashes, wide nasal bridge, long philtrum, hypertrichosis, growth retardation, and intellectual disability. Cornelia de Lange syndrome (CdLS) is a rare disease characterized by synophrys, long eyelashes, limb abnormalities, generalized hirsutism, growth retardation, and intellectual disability. In both WDSTS and CdLS, the malformations are due to transcriptome disturbance caused by defects in the genes encoding the components of chromatin regulation and transcription process. The overlapping features in these two syndromes may complicate the original diagnosis of a patient. Here, we report on a Wiedemann-Steiner patient found to have a de novo pathogenic <i>KMT2A</i> variation who had been clinically suspected as CdLS. We suggest that targeted next-generation sequencing is a feasible tool for the precise diagnosis of patients who have phenotypically and clinically overlapping features of CdLS and WDSTS.


Sign in / Sign up

Export Citation Format

Share Document